These pricing developments sit alongside the CMS BALANCE model, which opens Medicare Part D and Medicaid coverage for GLP-1s as early as May 2026 when bundled with lifestyle support
The science behind bitter compounds and digestion Bitter foods and extracts have been consumed historically, and are often associated with digestive support and metabolic benefits
The first GLP-1 drug, exenatide (the brand name is Byetta), was approved in 2005
These medications are designed to be combined with a balanced diet and regular exercise to achieve optimal results and support healthy habits
This includes precise dosing, timing, and support that fits your lifestyle
It is worth noting that there does appear to be a trial administering BPC 157 (rectally administered) in human participants for the treatment and healing of acute to mild ulcerative colitis (Veljaca et al